Can artificial intelligence accelerate preclinical drug discovery and precision medicine?

Ali Farnoud¹, Alexander J Ohnmacht^{1

2}, Martin Meinel^{1

3}, Michael P Menden^{1

2

4}

Affiliations

¹ Institute of Computational Biology, Helmholtz Center Munich, Munich, Germany.
² Department of Biology, Ludwig-Maximilians University Munich, Munich, Germany.
³ Department of Dermatology and Allergy, Technical University Munich, Munich, Germany.
⁴ German Center for Diabetes Research (DZD e.V.), Munich, Germany.

Editorial

Ali Farnoud et al. Expert Opin Drug Discov. 2022 Jul.

. 2022 Jul;17(7):661-665.

doi: 10.1080/17460441.2022.2090540. Epub 2022 Jun 19.

Ali Farnoud¹, Alexander J Ohnmacht^{1

2}, Martin Meinel^{1

3}, Michael P Menden^{1

2

4}

¹ Institute of Computational Biology, Helmholtz Center Munich, Munich, Germany.
² Department of Biology, Ludwig-Maximilians University Munich, Munich, Germany.
³ Department of Dermatology and Allergy, Technical University Munich, Munich, Germany.
⁴ German Center for Diabetes Research (DZD e.V.), Munich, Germany.

No abstract available

Keywords: Artificial intelligence; biomarkers; deep learning; drug discovery; machine learning; pharmacogenomics; precision medicine.

Publication types